We are pleased to announce the publication of our latest study in Nature Cancer: “Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets.” Applying a 13-modality multi-omics approach to 173 treatment-naive individuals with AML, the study defines molecular subtypes and coalescent phenotypes across proteogenomic and metabolomic layers, offering a clinically and translationally informed unified view of this heterogeneous malignancy and nominating associated therapeutic targets. Congratulations to co-first author Chenwei Wang and the whole team on this outstanding collaborative effort!
Read the paper on PubMed.